These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 6089304)

  • 1. Effect of ranitidine on the content of glyceroglucolipids in gastric secretion of patients with gastric and duodenal ulcer.
    Sarosiek J; Slomiany BL; Slomiany A; Gabryelewicz A
    Scand J Gastroenterol; 1984 Jul; 19(5):650-4. PubMed ID: 6089304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of duodenal and gastric ulcer with ranitidine--a controlled, multicentre clinical trial.
    Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
    Dtsch Z Verdau Stoffwechselkr; 1982; 42(2-3):64-9. PubMed ID: 6286274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an oral morning dose of nizatidine and ranitidine on gastric acid secretion in duodenal ulcer patients.
    Lazzaroni M; Bianchi Porro G
    Hepatogastroenterology; 1989 Dec; 36(6):490-3. PubMed ID: 2575571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranitidine in the treatment of peptic ulcer.
    Makalinao AU; Zaño FM
    Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carprofen and the therapy of gastroduodenal ulcerations by ranitidine.
    Czarnobilski Z; Bem S; Czarnobilski K; Konturek SJ
    Hepatogastroenterology; 1985 Feb; 32(1):20-3. PubMed ID: 3872836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysolecithin and glyceroglucolipids in gastric secretion of patients with gastric and duodenal ulcer.
    Sarosiek J; Slomiany BL; Slomiany A; Gabryelewicz A
    Scand J Gastroenterol; 1983 Oct; 18(7):935-8. PubMed ID: 6676927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of H2-receptor blockade by ranitidine on ulcer healing and gastric acid secretion in patients with gastric and duodenal ulcers.
    Forssell H; Koch G
    Eur J Clin Pharmacol; 1983; 25(2):195-8. PubMed ID: 6313376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.
    Louw JA; Young GO; Lucke W; Bridger S; Winter TA; Marks IN
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):363-7. PubMed ID: 9789128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer.
    Hirschowitz BI
    Gastroenterology; 1984 May; 86(5 Pt 1):843-51. PubMed ID: 6423436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
    Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
    Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine: a pilot study in Japan.
    Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
    Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different HCl and pepsinogen I secretion patterns in anatomically defined gastric ulcer subsets.
    Albillos A; Alvarez-Mon M; Rossi I; Gonzalo MA; Marín MC; Abreu L
    Am J Gastroenterol; 1990 May; 85(5):535-8. PubMed ID: 2337056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric acid secretion and duodenal ulcer healing during treatment with omeprazole. A Scandinavian Multicentre Study.
    Scand J Gastroenterol; 1984 Oct; 19(7):882-4. PubMed ID: 6397846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between two different posologies of ranitidine on 24-hour gastric acidity in duodenal ulcer patients.
    Corinaldesi R; Sacco T; Paternicò A; Stanghellini V; Paparo GF; Fabbri L; Giacomoni E; Barbara L
    Int J Tissue React; 1986; 8(1):55-9. PubMed ID: 3949443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical analysis of the gastric secretory response of patients with duodenal ulcer in dependence of their age and duration of complaints.
    Mózsik G; Venter E; Schmelczer M; Kutas J; Nagy L; Tárnok F
    Acta Med Acad Sci Hung; 1981; 38(2):117-28. PubMed ID: 7324803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sham feeding on gastric acid secretion in healthy subjects and duodenal ulcer patients: evidence for increased basal vagal tone in some ulcer patients.
    Feldman M; Richardson CT; Fordtran JS
    Gastroenterology; 1980 Nov; 79(5 Pt 1):796-800. PubMed ID: 7419002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ranitidine or nocloprost on the selected gastric juice components in the patients with the gastric ulcer.
    Skrodzka D; Gabryelewicz A
    Rocz Akad Med Bialymst; 1997; 42(1):257-66. PubMed ID: 9581490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
    Bories P; Tournade JM; Alberola B; Pappo M
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.